OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mode of delivery and content of communication strategies used in mandatory and non-mandatory biosimilar transitions: a systematic review with meta-analysis
Chiara Gasteiger, Alfons A den Broeder, Sarah Stewart, et al.
Health Psychology Review (2021) Vol. 17, Iss. 1, pp. 148-168
Open Access | Times Cited: 9

Showing 9 citing articles:

The Nocebo Effect
Luana Colloca
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 171-190
Closed Access | Times Cited: 31

Moving forward: Implementing health psychology research to improve patient acceptance of biosimilars
Chiara Gasteiger, Keith J. Petrie
Research in Social and Administrative Pharmacy (2022) Vol. 18, Iss. 10, pp. 3860-3863
Closed Access | Times Cited: 11

Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
Evrydiki Kravvariti, Maria‐Iosifina Kasdagli, Konstantina Maria Diomatari, et al.
Osteoporosis International (2023) Vol. 34, Iss. 3, pp. 585-598
Closed Access | Times Cited: 6

Health Care Providers’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar
Chiara Gasteiger, Maria Lobo, Lun Shen Wong, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 12, pp. 644-651
Open Access | Times Cited: 4

Rheumatology Patients’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar
Chiara Gasteiger, Maria Lobo, Robin Stanley, et al.
ACR Open Rheumatology (2023) Vol. 6, Iss. 2, pp. 64-71
Open Access | Times Cited: 4

Recommendations for Interchangeability in a Growing Biosimilar Market in Latin America
Gilberto Castañeda‐Hernández, Manuel Espinoza, Luís Pino, et al.
Advances in Therapy (2024) Vol. 41, Iss. 12, pp. 4357-4368
Closed Access

An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study
Carlos Marras, María Labarga, Daniel Ginard, et al.
JMIR Formative Research (2024) Vol. 8, pp. e56553-e56553
Open Access

Pharmacists' confidence in explaining biosimilars to patients before a nationwide medicine change: A cross-sectional study
Chiara Gasteiger, Norina Gasteiger, Keith J. Petrie
Exploratory Research in Clinical and Social Pharmacy (2022) Vol. 8, pp. 100199-100199
Open Access | Times Cited: 2

Using family-centered communication to optimize patient-provider-companion encounters about changing to biosimilars: A randomized controlled trial
Chiara Gasteiger, Anna Perera, Rachael Yielder, et al.
Patient Education and Counseling (2022) Vol. 106, pp. 142-150
Closed Access | Times Cited: 1

Page 1

Scroll to top